Semaglutide reduces severity of common liver disease in people with HIV
Semaglutide reduces severity of common liver disease in people with HIV NIH-funded findings inform interdisciplinary…
Semaglutide reduces severity of common liver disease in people with HIV NIH-funded findings inform interdisciplinary…
— 21 local respite providers and organizations chosen as first recipients in five-year, $25 million…
The U.S. Food and Drug Administration (FDA) has approved the injected drug Skyrizi (risankizumab) to…
Vaginal ring and oral pre-exposure prophylaxis found safe for HIV prevention throughout pregnancy Multi-country findings…
CHICAGO, July 2, 2024 — The Alzheimer’s Association celebrates today’s U.S. Food and Drug Administration…
Hitting the gym hard when you reach retirement age may help you preserve mobility for…
More than half of American Indian youth may have abnormal or high cholesterol NIH-funded study…
As U.S. workforce ages, cognitive impairment in workplaces is on the rise New paper from…
What does it take to live to be 100 years old? If you answered good…
Long-acting HIV treatment benefits adults with barriers to daily pill taking and adolescents with suppressed…